isoxazoles has been researched along with Latent Tuberculosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debonis, J; Mysler, E; Schijedman, A; Tamborenea, MN; Tate, G | 1 |
| Houtman, PM; Jansen, TL; Kwakernaak, AJ; Spoorenberg, JP; Weel, JF | 1 |
2 other study(ies) available for isoxazoles and Latent Tuberculosis
| Article | Year |
|---|---|
Prevalence of positive ppd in a cohort of rheumatoid arthritis patients.
Topics: Adult; Aged; Antirheumatic Agents; Argentina; Arthritis, Rheumatoid; Biological Products; Cross-Sectional Studies; Female; Humans; Isoxazoles; Latent Tuberculosis; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; Steroids; Treatment Outcome; Tuberculin Test; Tumor Necrosis Factor-alpha | 2010 |
A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
Topics: Arthritis, Rheumatoid; Azathioprine; Biological Assay; CD4-Positive T-Lymphocytes; Female; Glucocorticoids; Humans; Immunity, Cellular; Interferon-gamma; Isoxazoles; Latent Tuberculosis; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Tuberculin Test; Tumor Necrosis Factor-alpha | 2011 |